Rick Winningham | executive |
Aine Miller | executive |
Rhonda Farnum | executive |
Aziz Sawaf | executive |
Douglas Tsao | analyst |
Julian Harrison | analyst |
David Risinger | analyst |
Marc Frahm | analyst |
Jingming Chen | analyst |
Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma First Quarter 2024 Conference Call. [Operator Instructions]. Also, today's conference call is being recorded.
And now I would like to turn the call over to Rick Winningham, Chief Executive Officer.